| Title : HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer's-associated markers - Salari_2024_Metab.Brain.Dis_40_74 |
| Author(s) : Salari A , Roghani M , Khalili M |
| Ref : Metabolic Brain Disease , 40 :74 , 2024 |
| Abstract : |
| PubMedSearch : Salari_2024_Metab.Brain.Dis_40_74 |
| PubMedID: 39704877 |
| Title : HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer's-associated markers - Salari_2024_Metab.Brain.Dis_40_74 |
| Author(s) : Salari A , Roghani M , Khalili M |
| Ref : Metabolic Brain Disease , 40 :74 , 2024 |
| Abstract : |
| PubMedSearch : Salari_2024_Metab.Brain.Dis_40_74 |
| PubMedID: 39704877 |
| Title : HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer's-associated markers - Salari_2024_Metab.Brain.Dis_40_74 |
| Author(s) : Salari A , Roghani M , Khalili M |
| Ref : Metabolic Brain Disease , 40 :74 , 2024 |
| Abstract : |
| PubMedSearch : Salari_2024_Metab.Brain.Dis_40_74 |
| PubMedID: 39704877 |